Charlie Petty

Managing Director · Adjuvant Capital

Charlie Petty is a life sciences investor who co-founded Adjuvant Capital, a venture firm that invests

0–

5 million in early-stage companies developing vaccines, therapeutics, and diagnostics for high-burden and neglected diseases in low- and middle-income countries[2][3][5]. His notable portfolio includes clinical-stage biotechs such as Excision Biotherapeutics, Codagenix, VitriVax, Minervax,…

Stages: Pre-Seed, Seed
Location: New York, New York, United States

Website

Browse all investors · Browse founders